- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
High Tide
Market Cap: CA$279.3m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.09
7D
-9.1%
1Y
-1.0%
Verano Holdings
Market Cap: CA$544.9m
Engages in the cannabis business in the United States.
VRNO
CA$1.50
7D
-0.7%
1Y
53.1%
Aurora Cannabis
Market Cap: CA$263.7m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.51
7D
-4.0%
1Y
-29.4%
Curaleaf Holdings
Market Cap: CA$2.5b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$3.01
7D
-6.8%
1Y
135.2%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$8.50
7D
-5.5%
1Y
-0.1%
Medexus Pharmaceuticals
Market Cap: CA$101.2m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.05
7D
-2.9%
1Y
13.0%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.12
7D
0%
1Y
84.6%
Cresco Labs
Market Cap: CA$618.9m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.28
7D
-4.5%
1Y
25.5%
Trulieve Cannabis
Market Cap: CA$1.7b
Operates as a cannabis retailer in the United States.
TRUL
CA$8.23
7D
-6.3%
1Y
41.9%